3 months ago
PRAX
AnalystsDavid HoangDavid Hoang's Stock Forecasts
AnalystsDavid Hoang
Sectors:
Analyst Ranking
Top 10%
#517 out of 5185 analysts
Average Return
+20.84%
Win Rate
67%28 out of 42
Risk vs Reward
Poor
Good
David Hoang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +272.74% | $84.24 | $314.00 | 2025-02-11 - 2026-01-30 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +181.99% | $21.27 | $59.98 | 2024-02-16 - 2024-11-29 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +139.44% | $9.00 | $21.55 | 2025-02-11 - 2026-01-30 | Strong Buy |
Spyre Therapeutics IncSYRE | +96.92% | $16.24 | $31.98 | 2025-09-26 - 2026-01-30 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +95.12% | $30.74 | $59.98 | 2024-07-02 - 2024-11-29 | Strong Buy |
David Hoang Analyst Color
Get additional color on David Hoang's coverage of popular stocks
7 months ago
HRMY
10 months ago
ALKS
a year ago
SRPT
David Hoang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $103.00 | +57.23% | Initiates Coverage On | 2 months ago |
Alkermes PLCALKS | 3 | Strong Buy | $45.00 | +32.78% | Maintains | 3 months ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $280.00 | -10.83% | Maintains | 3 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $43.00 | +34.46% | Initiates Coverage On | 4 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Strong Buy | $36.00 | -1.42% | Maintains | 4 months ago |
Sarepta Therapeutics IncSRPT | 10 | Strong Sell | $12.00 | -41.00% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $35.00 | +39.28% | Upgrades | 8 months ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $67.00 | +63.37% | Initiates Coverage On | a year ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $31.00 | +42.59% | Initiates Coverage On | a year ago |
Biohaven LtdBHVN | 1 | Strong Buy | $65.00 | +449.45% | Initiates Coverage On | a year ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $176.00 | -4.48% | Initiates Coverage On | a year ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $12.00 | -44.32% | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 4 | Hold | $158.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Sage Therapeutics IncSAGE | 1 | Strong Sell | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $220.00 | N/A | Initiates Coverage On | 3 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Provention Bio IncPRVB | 1 | Hold | $25.00 | N/A | Downgrades | 3 years ago |
Gossamer Bio IncGOSS | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Orchard Therapeutics PLCORTX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.